Bristol-Myers Squibb's Devens Investment Tops $1 Billion for Biological Manufacturing
Bristol-Myers Squibb's Devens Investment Tops $1 Billion for Biological Manufacturing
SUGAR LAND--May 6, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Twenty years ago, the U.S. Army ceased operations at Fort Devens, Massachusetts, and then sold it for $17 million to MassDevelopment, the state's finance and development agency. The base and most of its land were transformed into what is known as a regional enterprise. The investment paid off in a big way in 2006 when the $1 billion "Project Hummingbird" landed in Devens. Within this article: Describes investments in Devens Massachusetts by Bristol-Myers Squibb (NYSE:BMS)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Contractor DPR Construction at Work on $8.8 Billion in U.S. Projects
- ISPE Names the 2017 Pharmaceutical Facility of the Year Category Awards
- Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activi...
- Pharm-Bio Building Boom: More than $20 Billion Set for 2014 North American ...
- Washington State Sees $13.8 Billion Worth of Projects Under Construction